In January 2026, a significant change in cervical cancer screening was introduced by the Health Resources and Services Administration. This update allows individuals to opt for self-testing for the human papillomavirus (HPV) as an alternative to traditional Pap smears or in-office cervical cancer screenings. The hope behind this initiative is to boost screening rates for HPV, the virus responsible for a vast majority of cervical cancer cases.
A recent study published in JAMA Network Open delves into who is choosing these at-home testing options. Researchers from The Permanente Medical Group and Kaiser Permanente Northern California found that while a notable portion of eligible patients are embracing self-collection, more concentrated outreach is necessary to ensure equitable participation across all demographic groups.
The authors of the study noted, "The findings suggest that a substantial proportion of eligible patients will elect home-based screening, but efforts are needed to support participation across demographic groups."
Interest in Home HPV Kits Emerges
Kaiser Permanente Northern California researchers surveyed 13,714 patients, all of whom were either due for or overdue for their routine cervical cancer screening. They inquired about a preference for home-based testing. The patient group represented a diverse range of backgrounds, including 3,577 Asian or Pacific Islanders (26.1%), 844 Black individuals (6.2%), 2,870 Hispanic individuals (20.9%), 5,357 White individuals (39.1%), and 1,066 individuals identifying as mixed-race (7.8%).
Out of this surveyed group, 2,557 individuals (18.6%) requested a self-screening kit, which included a flocked swab for sample collection. The data indicated that older patients, those with certain pre-existing health conditions, and White individuals were more inclined to request a home test. White patients constituted the largest segment of those opting for self-tests, with 1,264 (49.4%) making this choice. More than half of the individuals who received kits, specifically 1,382 (54%), returned them within two months. Those who successfully returned their kits tended to be 45 years or older, had a history of consistent HPV screenings, and were White.
The study suggests that a higher uptake among older patients might be linked to their familiarity with cancer screenings, increased concern about cancer, or potential discomfort with pelvic examinations.
Conversely, individuals who were significantly overdue for their screenings, had inconsistent screening histories, a higher body mass index, or a greater number of health complications were less likely to return their kits. The authors posited that this pattern might also be indicative of "lower health system engagement."
While approximately one in five eligible patients expressed interest in a self-test, only about one in ten ultimately returned their kits. The researchers believe that an individual’s prior experiences and engagement with the healthcare system likely play a role in their willingness to utilize at-home testing options.